Award Year / Program / Phase:
2004 / STTR / Phase I
Agency:
HHS
Research Institution:
UNIVERSITY OF NEBRASKA LINCOLN
DESCRIPTION (provided by applicant): The primary objective of this Phase I STTR project is to develop an effective, peptide-based nicotine vaccine for use in humans capable of inducing a robust, nicotine-specific antibody (Ab) response with little or no inflammatory side effects. This will be…
More